http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35040780

Outgoing Links

Predicate Object
contentType Journal Article
issn 2047-783X
issueIdentifier 1
pageRange 123-
publicationName European Journal of Medical Research
startingPage 123
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e6f5aee94bed5d4755dfa0efc36fb38d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0d27e8a868f80c3988f264741ee87133
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f75c1cfa973fe83ae567dedef1e1f307
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd344ea6f1cfcba7d895c7a87964dbd2
bibliographicCitation Yao N, Jiang W, Wang Y, Song Q, Cao X, Zheng W, Zhang J. An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma. Eur J Med Res. 2023 Mar 15;28(1):123. PMID: 36918943; PMCID: PMC10015788.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d5a8e8eeb4126e35d352a14323f4614
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_637a5b8ec7e5b5d8fa3d9e2a78dc94bb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bedb5fa97c1d66676a09e33b77cb1f00
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f958fffbcc4ce24ba7335015b2aa0196
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79f4bc1d027ed0dd61e58a1da8b82686
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae80a0b19af16277001d67dd7f477c14
date 2023-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1186/s40001-023-01091-w
https://pubmed.ncbi.nlm.nih.gov/PMC10015788
https://pubmed.ncbi.nlm.nih.gov/36918943
isPartOf https://portal.issn.org/resource/ISSN/2047-783X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20501
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma
discusses http://id.nlm.nih.gov/mesh/M0011490
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40839
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6851740
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_132a8504e7423e57e5565c4615cd0cd2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1f89d53127fac03812c245bc89053817
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f

Total number of triples: 41.